SA-modified Nanoparticles

Updated: 2026-09-13

Overview

SA-modified Nanoparticles are advanced nanomaterials featuring surface-bound sialic acid (SA), a naturally occurring sugar molecule critical for cellular communication. This modification imparts unique biointerfacial properties, making them particularly valuable in biomedical applications where stealth and targeted interactions are required. The technology builds upon decades of glycobiology research, with commercial production emerging in the early 2010s. These engineered particles typically consist of metallic (e.g., gold), polymeric, or silica cores functionalized with SA derivatives through covalent conjugation. The degree of modification can be precisely controlled during synthesis, allowing customization for specific biological applications. Major pharmaceutical and biotechnology companies are increasingly adopting SA-modified platforms for next-generation therapeutic development.

Physical and Chemical Properties

The physical characteristics of SA-modified Nanoparticles are primarily determined by their core material, with common sizes ranging from 20-200 nm in diameter. Surface modification with sialic acid introduces negative charges at physiological pH due to the carboxylate groups, significantly altering the particles' zeta potential. This change improves colloidal stability in biological fluids while reducing non-specific protein adsorption. Chemically, the SA moieties enable specific recognition by siglec receptors and other biological targets. The modification process typically preserves the core material's intrinsic properties (e.g., magnetic responsiveness or fluorescence) while adding new biological functionality. Thermal stability varies by composition, with most formulations stable at biological temperatures but requiring protection from extreme heat during storage.

Main Applications

In drug delivery, SA-modified Nanoparticles demonstrate prolonged circulation times and enhanced accumulation in target tissues expressing complementary receptors. They are particularly effective for delivering nucleic acid therapeutics to immune cells and hepatocytes. Vaccine developers utilize these particles as adjuvants, leveraging SA's role in immune modulation to enhance both humoral and cellular responses. Diagnostic applications capitalize on the particles' ability to selectively bind biomarkers when conjugated with detection moieties. In cancer theranostics, SA-modified systems enable simultaneous tumor targeting, imaging contrast, and therapeutic payload delivery. Emerging uses include regenerative medicine, where they facilitate stem cell homing, and antimicrobial applications targeting pathogen adhesion mechanisms.

Safety and Storage

While generally considered biocompatible, SA-modified Nanoparticles require careful handling as respirable particulates. Standard nanoparticle precautions apply: use fume hoods for powder handling, wear appropriate PPE, and implement engineering controls to prevent airborne exposure. Material Safety Data Sheets (MSDS) should be consulted for specific formulations. Storage conditions are critical for maintaining functionality. Lyophilized formulations offer longest shelf life (12-24 months at -20°C), while aqueous suspensions typically remain stable for 3-6 months at 2-8°C. Avoid repeated freeze-thaw cycles and protect from light for photosensitive formulations. Sterile filtration is recommended for in vivo applications, with endotoxin levels <0.25 EU/mL for clinical-grade materials.

B2B Procurement Guide

Industrial buyers should specify exact requirements including: core material composition, SA density (molecules/nm²), hydrodynamic diameter (with PDI), surface charge, endotoxin levels, and sterilization status. Batch-to-batch consistency is crucial for regulatory compliance in pharmaceutical applications. Leading manufacturers typically offer custom conjugation services with minimum order quantities of 1-10g for research-grade materials, scaling to kilogram quantities for GMP production. Pricing tiers reflect purification level (e.g., HPLC-purified SA conjugates command premium pricing). Consider suppliers with ISO 13485 certification for medical applications, and request comprehensive characterization data including DLS, TEM, and HPLC analysis with each batch.